Results 111 to 120 of about 41,008 (260)

Sex differences in genomics, immune microenvironment and immunotherapy response in adult grade 4 gliomas

open access: yesClinical and Translational Discovery, Volume 6, Issue 2, April 2026.
Overall survival of patients with brain tumors receiving ICIs treatment Abstract Purpose Sex differences in the prevalence of gliomas have been reported; however, whether there are sex differences in the development and immunotherapy of gliomas remains poorly understood.
Feng Tang   +4 more
wiley   +1 more source

A Review of CEBPA's Role in Hereditary Leukemia

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Background Advances in genetic testing have allowed for extensive testing and identification of previously unrecognized inherited conditions; a prominent area of this research includes familial patterns of acute myeloid leukemia (AML). Recognition of familial related hematologic malignancies can have lasting implications for both patients and ...
Tara Rakiewicz, Neil Palmisiano
wiley   +1 more source

Comunidades desenclaustradas en cuatro poetas mapuche

open access: yesRevista Chuy, 2019
La poesía mapuche contemporánea constituye uno de los fenómenos literarios más llamativos de las últimas décadas en la región. Su profusión y heterogeneidad hace de esta escritura una presencia notable. Los procesos de des(re)territorialización a los que
María Fernanda Libro
doaj   +2 more sources

Real‐World Analysis of Outcomes of Venetoclax+Azacitidine Versus 7+3 Induction in Acute Myeloid Leukemia

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Background Venetoclax plus azacitidine (V+A) is standard for older, intensive‐ineligible patients with acute myeloid leukemia (AML). Its expanding use in younger, curative‐eligible adults lacks comparative evidence against conventional 7+3 induction, raising uncertainty about potential survival compromise.
Nehemias Guevara Rodriguez   +6 more
wiley   +1 more source

Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9 [PDF]

open access: bronze, 2019
Hans‐Georg Wirsching   +9 more
openalex   +1 more source

Supplementary Figure from Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, <i>IDH</i>-wildtype: <i>Post Hoc</i> Analysis of the EORTC Randomized Phase III CATNON Trial

open access: gold, 2023
C. Mircea S. Tesileanu   +36 more
openalex   +1 more source

Mapping Intracellular Volume Fraction With Susceptibility Source Decomposition as a Marker for Tissue Cellularity

open access: yesJournal of Magnetic Resonance Imaging, Volume 63, Issue 4, Page 1092-1105, April 2026.
ABSTRACT Background Pathophysiological changes affect tissue cell composition and density. For example, neurodegenerative disorders and brain tumors are associated with cell loss and abnormal accumulation, respectively. In these scenarios, if monitored and tracked, tissue cellularity might be used to inform clinical diagnosis and management. Purpose To
Giulia Debiasi   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy